Specialty Pharmacy And Home Health Expansion Will Create Lasting Opportunity
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 12 Analysts
Published
26 May 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
US$28.71
22.0% undervalued intrinsic discount08 Aug
US$22.39
1Y
87.5%7D
9.4%